NANOSPHERE HEA.SCIENCES
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more
NANOSPHERE HEA.SCIENCES (2CG) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NANOSPHERE HEA.SCIENCES (2CG) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NANOSPHERE HEA.SCIENCES - Net Assets Trend (None–None)
This chart illustrates how NANOSPHERE HEA.SCIENCES's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NANOSPHERE HEA.SCIENCES (None–None)
The table below shows the annual net assets of NANOSPHERE HEA.SCIENCES from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NANOSPHERE HEA.SCIENCES's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NANOSPHERE HEA.SCIENCES Competitors by Market Cap
The table below lists competitors of NANOSPHERE HEA.SCIENCES ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
UNDER ARMOUR-A (U9R.SG)
STU:U9R
|
$53.57K |
|
CIA Energetica Do Ceara - COELCE
SA:COCE6
|
$53.57K |
|
SEPLAT ENERGY PLC
XNSA:SEPLAT
|
$53.58K |
|
Liberty Northwest Bancorp Inc.
OTCQX:LBNW
|
$53.60K |
|
DFS Furniture PLC
LSE:DFS
|
$53.42K |
|
NATIONAL MICROFINANCE BANK PLC
DSE:NMB
|
$53.31K |
|
Investec Limited NON RED NON CUM NON PTG PRF ZAR0.01
JSE:INPR
|
$53.29K |
|
NOS (PMV.SG)
STU:PMV
|
$53.28K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NANOSPHERE HEA.SCIENCES's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NANOSPHERE HEA.SCIENCES's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NANOSPHERE HEA.SCIENCES utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NANOSPHERE HEA.SCIENCES's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NANOSPHERE HEA.SCIENCES (2CG) | €- | N/A | N/A | $53.56K |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |